دورية أكاديمية
أعرض في EDS

Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

التفاصيل البيبلوغرافية
العنوان: Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
المؤلفون: Jacobs, Samuel A.Aff1, Robidoux, AndréAff1, Aff2, Abraham, JameAff1, Aff3, Pérez-Garcia, José ManuelAff4, Aff5, La Verde, NiclaAff6, Aff7, Orcutt, James M.Aff1, Aff8, Cazzaniga, Marina E.Aff5, Aff9, Piette, Fanny, Antolín, Silvia, Aguirre, Elena, Cortes, JavierAff4, Aff5, Llombart-Cussac, Antonio, Di Cosimo, SerenaAff5, Aff12, Kim, Rim S., Feng, Huichen, Lipchik, Corey, Lucas, Peter C.Aff1, Aff13, Srinivasan, Ashok, Wang, Ying, Song, Nan, Gavin, Patrick G., Balousek, April D., Paik, SoonmyungAff1, Aff14, Allegra, Carmen J., Wolmark, NormanAff1, Aff16, Pogue-Geile, Katherine L.
المصدر: Breast Cancer Research. 22(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:1465542X
DOI:10.1186/s13058-019-1240-y